Stay updated on ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial
Sign up to get notified when there's something new on the ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial page.

Latest updates to the ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section now states that items are automatically filled from PubMed and may not be about the study, and the revision version updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding lapse notice at the top of the page has been removed. This banner warned that information may not be up to date and NIH operations could be affected, and it did not alter the trial content.SummaryDifference0.4%

- Check42 days agoChange DetectedThe new screenshot shows minor UI and layout adjustments on the study page with core trial details (title, conditions, interventions, outcomes, enrollment, and eligibility) remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference5%

- Check78 days agoChange DetectedAdded a new version label (v3.1.0); removed several drug-safety sections and an older version tag (v3.0.2).SummaryDifference0.6%

- Check92 days agoChange DetectedUpdated Revision to v3.0.2 (from v3.0.1); removed the 'Back to Top' link.SummaryDifference0.3%

Stay in the know with updates to ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial page.